Global action plan on HIV drug resistance 2017–2021
![Global action plan on HIV drug resistance 2017–2021](https://iris.who.int/bitstream/handle/10665/255883/9789241512848-eng.pdf.jpg?sequence=4)
Übersicht
Preventing and managing the emergence of HIVDR is a key component of a comprehensive and effective HIV response, and should be integrated into broader efforts to ensure sustainability and greatest impact. It is essential that actions to monitor, prevent and respond to HIVDR are implemented at the clinical, programme and policy levels to address the many drivers of HIVDR.
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant and breastfeeding women, children and adolescents.
The Global Action Plan has five strategic objectives:
- prevention and response;
- monitoring and surveillance;
- research and innovation;
- laboratory capacity; and
- governance and enabling mechanisms.
It is built on the guiding principles of a public health approach; comprehensive, coordinated and integrated action; country ownership; a focus on high-impact countries; sustainable investment; and use of standardized methods to monitor resistance and achieve impact from actions.